Metastatic squamous cell carcinoma is associated with a lower disease-specific survival in immunosuppressed patients: A matched case-control study.
Publication
, Journal Article
Wackel, M; Plampton, K; Georgesen, C; Wysong, A; Whitley, MJ
Published in: J Am Acad Dermatol
December 2022
Duke Scholars
Published In
J Am Acad Dermatol
DOI
EISSN
1097-6787
Publication Date
December 2022
Volume
87
Issue
6
Start / End Page
1410 / 1411
Location
United States
Related Subject Headings
- Immunocompromised Host
- Humans
- Head and Neck Neoplasms
- Dermatology & Venereal Diseases
- Case-Control Studies
- Carcinoma, Squamous Cell
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Wackel, M., Plampton, K., Georgesen, C., Wysong, A., & Whitley, M. J. (2022). Metastatic squamous cell carcinoma is associated with a lower disease-specific survival in immunosuppressed patients: A matched case-control study. J Am Acad Dermatol, 87(6), 1410–1411. https://doi.org/10.1016/j.jaad.2022.08.042
Wackel, Megan, Katherine Plampton, Corey Georgesen, Ashley Wysong, and Melodi Javid Whitley. “Metastatic squamous cell carcinoma is associated with a lower disease-specific survival in immunosuppressed patients: A matched case-control study.” J Am Acad Dermatol 87, no. 6 (December 2022): 1410–11. https://doi.org/10.1016/j.jaad.2022.08.042.
Wackel M, Plampton K, Georgesen C, Wysong A, Whitley MJ. Metastatic squamous cell carcinoma is associated with a lower disease-specific survival in immunosuppressed patients: A matched case-control study. J Am Acad Dermatol. 2022 Dec;87(6):1410–1.
Wackel, Megan, et al. “Metastatic squamous cell carcinoma is associated with a lower disease-specific survival in immunosuppressed patients: A matched case-control study.” J Am Acad Dermatol, vol. 87, no. 6, Dec. 2022, pp. 1410–11. Pubmed, doi:10.1016/j.jaad.2022.08.042.
Wackel M, Plampton K, Georgesen C, Wysong A, Whitley MJ. Metastatic squamous cell carcinoma is associated with a lower disease-specific survival in immunosuppressed patients: A matched case-control study. J Am Acad Dermatol. 2022 Dec;87(6):1410–1411.
Published In
J Am Acad Dermatol
DOI
EISSN
1097-6787
Publication Date
December 2022
Volume
87
Issue
6
Start / End Page
1410 / 1411
Location
United States
Related Subject Headings
- Immunocompromised Host
- Humans
- Head and Neck Neoplasms
- Dermatology & Venereal Diseases
- Case-Control Studies
- Carcinoma, Squamous Cell
- 3202 Clinical sciences
- 1103 Clinical Sciences